[{"address1": "444 West Lake Street", "address2": "Suite 1700", "city": "Chicago", "state": "IL", "zip": "60606", "country": "United States", "phone": "312 416 8592", "website": "https://www.MAIABiotech.com", "industry": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "MAIA Biotechnology, Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of therapies targeting cancer. The company's lead product candidate is THIO, a telomere-targeting agent that is in Phase II clinical study to evaluate its activity in patients with non-small cell lung cancer. It is also developing second generation telomere targeting agents. MAIA Biotechnology, Inc. was incorporated in 2018 and is headquartered in Chicago, Illinois.", "fullTimeEmployees": 13, "companyOfficers": [{"maxAge": 1, "name": "Dr. Vlad  Vitoc M.B.A., M.D.", "age": 52, "title": "Co-Founder, President, CEO & Chairman of the Board of Directors", "yearBorn": 1971, "fiscalYear": 2022, "totalPay": 715550, "exercisedValue": 0, "unexercisedValue": 3248211}, {"maxAge": 1, "name": "Dr. Sergei M. Gryaznov Ph.D.", "age": 63, "title": "Chief Scientific Officer", "yearBorn": 1960, "fiscalYear": 2022, "totalPay": 524769, "exercisedValue": 0, "unexercisedValue": 1457995}, {"maxAge": 1, "name": "Mr. Jeffrey C. Himmelreich", "title": "Head of Finance", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Linda  Moreira", "title": "Company Secretary", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400, "priceHint": 4, "previousClose": 2.205, "open": 2.23, "dayLow": 1.98, "dayHigh": 2.23, "regularMarketPreviousClose": 2.205, "regularMarketOpen": 2.23, "regularMarketDayLow": 1.98, "regularMarketDayHigh": 2.23, "forwardPE": -1.2911391, "volume": 195739, "regularMarketVolume": 195739, "averageVolume": 397296, "averageVolume10days": 206950, "averageDailyVolume10Day": 206950, "bidSize": 1000, "askSize": 900, "marketCap": 40805712, "fiftyTwoWeekLow": 0.82, "fiftyTwoWeekHigh": 4.25, "fiftyDayAverage": 1.74546, "twoHundredDayAverage": 1.740385, "currency": "USD", "enterpriseValue": 33655072, "floatShares": 14548655, "sharesOutstanding": 20002800, "sharesShort": 845080, "sharesShortPriorMonth": 388770, "sharesShortPreviousMonthDate": 1709164800, "dateShortInterest": 1711584000, "sharesPercentSharesOut": 0.0422, "heldPercentInsiders": 0.21428, "heldPercentInstitutions": 0.03903, "shortRatio": 1.47, "shortPercentOfFloat": 0.050300002, "bookValue": 0.028, "priceToBook": 72.85714, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1703980800, "netIncomeToCommon": -19772904, "trailingEps": -1.49, "forwardEps": -1.58, "exchange": "ASE", "quoteType": "EQUITY", "symbol": "MAIA", "underlyingSymbol": "MAIA", "shortName": "MAIA Biotechnology, Inc.", "longName": "MAIA Biotechnology, Inc.", "firstTradeDateEpochUtc": 1659015000, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "0f42043f-a188-3808-9a57-e38f76c4260b", "gmtOffSetMilliseconds": -14400000, "currentPrice": 2.04, "targetHighPrice": 14.0, "targetLowPrice": 11.25, "targetMeanPrice": 12.63, "targetMedianPrice": 12.63, "recommendationMean": 2.0, "recommendationKey": "buy", "numberOfAnalystOpinions": 2, "totalCash": 7150695, "totalCashPerShare": 0.357, "quickRatio": 1.478, "currentRatio": 1.532, "returnOnAssets": -1.28787, "returnOnEquity": -4.4011703, "freeCashflow": -7416974, "operatingCashflow": -13071016, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-04-16"}]